ALLO vs LYFT · rev $22.0K vs P/E 108, rev $5.79B
Allogene Therapeutics Inc (ALLO) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
ALLO currently screens at market cap $258.1M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the ALLO and LYFT stock pages for the full models.
Not investment advice.